Status:
RECRUITING
Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT
Lead Sponsor:
Mahidol University
Conditions:
Intravenous
Thrombosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Acute ischemic stroke is one of the devastating diseases that increase hospitalization, disabilities, and deaths worldwide. Current treatment with intravenous thrombolytic agent can help reduce disabi...
Eligibility Criteria
Inclusion
- Diagnosed as Acute ischemic stroke within 4.5 hr of symptom onset
- Age \> 18 years old
- No contraindication for thrombolytic drug
- Informed consent from patients
Exclusion
- Diagnosed as Acute ischemic stroke with more than 4.5 hours of symptom onset or uncontained onset
- Have contraindication for thrombolytic drugs
Key Trial Info
Start Date :
August 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06498323
Start Date
August 3 2022
End Date
August 31 2025
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siriraj Stroke Center,Siriraj Hospital
Bangkok, Thailand, 10700